Pexels.com
Eleven drugs were recalled in March to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
Such recalls are voluntary actions carried out by drug makers to remove potentially defective medicines from the market, the FDA said. They may be initiated either by the manufacturer or the FDA.
---
Drug Recalls for March
| Date | Brand Name | Product Description | Reason / Problem | Company |
| March 25 | Legacy | Losartan Potassium USP | Impurity found | Legacy Pharmaceutical Packaging |
| March 22 | Leopard | Dietary Supplement | Undeclared sildenafil | USA LESS |
| March 21 | Blue
Fusion | Capsules marketed as a
dietary supplement for male enhancement | Tainted with sildenafil, tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin and daidzein | Ata Int. Inc. |
| March 18 | Mylan | Levoleucovorin Injection, 250 mg/25 mL | Due to the presence of
particulate matter identified as copper salts | Mylan Institutional LLC |
| March 15 | Legacy | Losartan Potassium USP | Impurity found | Legacy Pharmaceutical Packaging |
| March 15 | Hospira | Sodium bicarbonate injection USP | Particulate matter | Hospira Inc. |
| March 5 | Life-Line tm | Additive for human drinking water | Potentially contaminated with Pseudomonas aeruginosa | McDaniel Life-Line LLC |
| March 4 | Apotex Corp. | Drospirenone and Ethinyl Estradiol Tablets, USP | May contain defective blisters | Apotex Corp. |
| March 1 | Sunstone Organics | White Vein Kratom and Maeng Da Kratom | Potential for salmonella | Sunstone Organics |
| March 1 | Torrent Pharma | Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide Tablets USP | Contains
N-Methylnitrosobutyric acid (NMBA) | Torrent Pharmaceuticals Limited |
| March 1 | Aurobindo, Acetris | Valsartan and Amlodipine and Valsartan tablets | Contains
N-nitrosodiethylamine (NDEA), | AurobindoPharma USA Inc. |
